CDK1 and clear cell renal carcinoma: Finally, we have reasons to believe that NCAPG promoted the proliferation and progression of renal clear cell carcinoma via mediating CDK1, and NCAPG/CDK1 complex might provide a new strategy for the treatment of renal clear cell carcinoma.